AGEN: Agenus Company Short-Term Debt
Agenus (AGEN) specializes in creating innovative tools for immune system enhancement and disease combat. The company's US plants develop therapeutic antibodies and vaccines, ensuring stability through project diversification. This chart on the GURU.Markets platform reflects the asset's price action, where the current indicator is 0.00. Business viability relies on partnership licenses and FDA approval.
Metric breakdowns and analytics for Agenus, Inc (AGEN)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
- net income and valuation multiples indicators:
Initial company analysis:AGEN - Agenus Inc.
Minimizing short-term liabilities reduces the financial vulnerability of Agenus (AGEN) to rate volatility. For a company whose success depends on clinical trials of immunotherapeutic drugs, liquidity control is critical prior to finalizing licensing agreements. The dynamics of short-term loan volumes reflect the total debt maturing within one year, measuring the speed of capital adaptation to the cost of money. Reducing this volume protects against interest expenses, which determines the stability of operating profit.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|precigen.com - Company Short-Term Indebtedness|Company Short-Term Debts PHAR (Pharming Group)|Nektar Therapeutics Inc (NKTR) - Short-Term Debt|Upstream Bio Corp - Company Short-Term Debts|ZBIO - Company Short-Term Debts|IMNM: Company Short-Term Debts|Short-Term Indebtedness gossamerbio.com GOSS|KALV (KalVista Pharmaceuticals, Inc.) - Company Short-Term Debts|Short-Term Debt Septerna, Inc. SEPN|Company Short-Term Debt Pieris Pharmaceuticals Inc (PVLA)|Savara Pharma - Company Short-Term Indebtedness|Rigel Pharmaceuticals - Company Current Liabilities|Company Short-Term Debts anaptysbio.com ANAB|ATXS - Company Short-Term Debt|Short-Term Debt Volume enGene Holdings Inc ENGN|RAPT: Company Short-Term Debts|Aerovate Therapeutics (JBIO) - Company Short-Term Debts|ACRS (Aclaris Therapeutics) - Company Short-Term Debts|KYTX - Short-Term Indebtedness|Company Short-Term Debts TLSA|CABA - Short-Term Debt|Company Short-Term Debt Ventyx Bio VTYX|THTX: Company Short-Term Indebtedness|AVTX - Company Short-Term Debt|Current Liabilities ELDN|CLYM: Company Short-Term Debts|zurabio.com - Company Short-Term Loans and Borrowings|ATYR (aTyr) - Company Short-Term Debts|Company Short-Term Debts Adagene Corp|Company Short-Term Debt ImageneBio Inc (IMA)|STTK (shattucklabs.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Equillium EQ|CNTB - Company Current Liabilities|Immunic Inc - Company Short-Term Debts|ATRA - Company Short-Term Debts|IFRX (inflarx.de) - Company Current Liabilities|x4pharma.com - Company Short-Term Loans and Borrowings|ACET (Adicet Bio Inc.) - Company Short-Term Debts|Celularity Corp (CELU) - Short-Term Debt Volume|Company Short-Term Debt INmune Bio Corp (INMB)|Company Current Liabilities Barinthus Biotherapeutics Corp BRNS|Company Short-Term Debt Kezar Life Sciences KZR|SABS - Company Current Liabilities|AKTX: Company Current Liabilities|ENLV - Company Short-Term Debts|q32bio.com (QTTB) - Company Short-Term Debt|Company Short-Term Indebtedness GOVX|EDSA (Edesa Biotech, Inc.) - Company Short-Term Debts|Short-Term Debt ibioinc.com IBIO|Company Short-Term Debts CARM|Company Short-Term Debts XTL Biopharmaceuticals Ltd (XTLB)|Company Short-Term Debts BOLT (Bolt Biotherapeutics, Inc.)|Short-Term Indebtedness HCW Biologics, Inc.|Aptevo - Company Short-Term Debts|Short-Term Debt aimimmuno.com|aditxt.com (ADTX) - Company Short-Term Debt|Company Short-Term Indebtedness GRI|Company Current Liabilities XRTX|Company Short-Term Debts Vyome Therapeutics|Company Short-Term Debt Revelation Biosciences (REVB)|Short-Term Debt Volume indaptusrx.com|Company Short-Term Debts SCNI (Scinai Immunotherapeutics Ltd.)|Company Short-Term Debts CalciMedica Inc CALI|Affimed Therapeutics - Company Short-Term Debts|Short-Term Indebtedness Allakos Inc. (ALLK)|HOOK: Company Short-Term Debts|Short-Term Debt IGM Biosciences (IGMS)|Company Short-Term Debt iTeos Therapeutics, Inc.|Company Short-Term Indebtedness OCEA (Ocean Biomedical Inc)|Company Short-Term Debt TC BioPharm (Holdings) PLC (TCBP)|THRD: Current Liabilities